Comparing musculoskeletal and connective tissue disorder risks of teriparatide and abaloparatide in osteoporosis: an analysis based on FDA adverse event reporting system (FAERS)

Ming‐Tao Wen(Shandong University of Traditional Chinese Medicine), Gang Li(Inner Mongolia Medical University), Peixue Ling(Shandong Academy of Pharmaceutical Sciences), Jiacheng Li(Children's Hospital of Chongqing Medical University), Bo‐Wen Lu(Shandong University of Traditional Chinese Medicine), Di Luo(Fujian University of Traditional Chinese Medicine), Fei Liu(First Affiliated Hospital of Zhengzhou University)
Expert Opinion on Drug Safety
July 17, 2024
Cited by 6


Related Papers